Search

Your search keyword '"Schnabel, Renate B."' showing total 1,260 results

Search Constraints

Start Over You searched for: Author "Schnabel, Renate B." Remove constraint Author: "Schnabel, Renate B."
1,260 results on '"Schnabel, Renate B."'

Search Results

202. Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries

203. Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study

205. The Association of Periodontitis and Peripheral Arterial Occlusive Disease in a Prospective Population-Based Cross-Sectional Cohort Study

207. Non-immune risk predictors of cardiac allograft vasculopathy: Results from the U.S. organ procurement and transplantation network

208. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) : the Task Force for the diagnosis and management of atrialfibrillation of the European Society of Cardiology (ESC) : developed with the special contribution of the European HeartRhythm Association (EHRA) of the ESC

209. Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death

210. Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality

211. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)

212. Cardiac Troponin I and Incident Stroke in European Cohorts : Insights From the BiomarCaRE Project

213. Rationale and Design of the Hamburg City Health Study

214. Cardiac Troponin I and Incident Stroke in European Cohorts:Insights From the BiomarCaRE Project

215. Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality

216. Neues beim Schlaganfall – Teil 1: Akuttherapie

218. Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device

219. Heart and brain interactions

220. Research Priorities in Atrial Fibrillation Screening

221. Risk prediction of atrial fibrillation in the community combining biomarkers and genetics

222. Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes

225. World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update

227. Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia

231. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

233. Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies

235. Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference

238. No impact of sex and age on beta‐adrenoceptor‐mediated inotropy in human right atrial trabeculae

240. Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry

241. Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort

244. Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death

245. Cardio‐Renal Biomarker Soluble Urokinase‐Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C‐Reactive Protein, and Renal Function

246. White Blood Cells and Blood Pressure

247. Tissue-specific multiOMICs analysis of atrial fibrillation

250. Multiple marker approach to risk stratification in patients with stable coronary artery disease

Catalog

Books, media, physical & digital resources